Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In vivo molecular imaging of angiogenesis after VEGF-D gene therapy
2018-001494-24Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Apr 2018
- Modality
- Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial in coronary arteriosclerosis comparing VEGF-D gene therapy with Placebo (2 arms). Primary endpoint: Change in myocardial angiogenesis. Started Apr 2018; status: completed.
02
Drugs
Ad-VEGF-D
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2018-001494-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001494-24.